Dr Saadvik Raghuram Y
Dr Saadvik Raghuram Y

MD (Gold Medalist), DM (Medical Oncology - AIMS), MRCP (UK), PDCR (Clinical Research), European Board Certified Medical Oncologist (ECMO)

  • HOD - Medical Oncology and Haematology
  • Arete Institute of Oncology

Language Known:

  • HindiHindi
  • EnglishEnglish
  • TeluguTelugu
  • 9+ years of extensive experience
  • Completed Diploma in Palliative Care from the Indian Association of Palliative Care
  • European board certified medical oncologist (ECMO)
  • Completed Professional Diploma in Clinical Research from Catalyst Clinical Services
  • Distinguished membership with International Oncology Societies
Know More About Dr Saadvik Raghuram Y

Dr Saadvik Raghuram Y is a distinguished Medical Oncologist with over 9 years of experience, known for his holistic and patient-centric approach to treating Cancer. He earned his medical degree from JSS Medical College Mysore, Karnataka, India, followed by a master's in Radiation Oncology from Sri Aurobindo Institute of Medical Sciences, Indore. He pursued his higher medical training in Medical Oncology from Amrita Institute of Medical Sciences, Kochi, solidifying his expertise in Cancer care.

Currently serving as the Head of the Department of Medical Oncology at Arete Hospitals, Dr Saadvik specialises in addressing a diverse range of Cancers, including Breast, Stomach, Colorectal, Liver, Esophageal, Prostate, Kidney, Bladder, Oral, Brain tumours, and Lung cancers. His clinical interest encompasses a broad-spectrum of procedures including , Immunotherapy, Monoclonal anitbodies, Chemotherapy Administration, Cancer Screening, Palliative Care, Targeted Therapy, Clinical Trials, Cancer Genetic Counseling, Hormone Therapy, etc.

Dr Saadvik’s meticulous attention to precise diagnosis and compassionate patient care distinguishes him within the medical community. Committed to staying at the forefront of oncology advancements, Dr Saadvik actively engages in research initiatives and participates in various workshops within the oncology domain. He has several publications in his credits, underscoring his dedication to advancing knowledge in the field. His passion and eagerness to learn makes him a valuable asset at Arete.

Qualifications
Experience
  • 2008-2014
    MBBS

    JSS Medical College Mysore, Karnataka, India

  • 2014-2017
    MD (Radiation Oncology)

    Sri Aurobindo Institute of Medical Sciences, Indore

  • 2017-2020
    DM (Medical Oncology)

    Amrita Institute of Medical Sciences, Kochi

  • 2021
    European Board Certified Medical Oncologist ( ECMO )
  • 2014
    Professional Diploma in Clinical Research

    Catalyst Clinical Services

  • 2014
    Diploma in Palliative Care

    Indian Association of Palliative Care

Focus Services and Treatment
  • Medical Oncology
  • Hemato-Oncology
  • Radiation Oncology
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
  • Hormonal Therapy 
  • Precision Oncology
  • Hereditary Cancer Detection
  • Gene Base Therapy
  • Next Generation Sequencing (NGS)
  • Palliative Care
Publications
  • Uppaluri KR, Kambalachenu HR, Challa HJ, Raghuram Y S, Gadicherla R, Ketavath S, Palasamudram K, Sri Manjari K. Mutations in a High-Grade Micropapillary Urothelial Carcinoma of the Renal Pelvis: A Case Report. Case Rep Oncol. 2023 Sep 20;16(1):972-979. doi: 10.1159/000530710. PMID: 37900819; PMCID: PMC10601746
  • Uppaluri, K. R., Kambalachenu, H. R., Challa, H. J., Y. Saadvik Raghuram, Sharma, D.,Gadicherla, R., Ketavath, S., Palasamudram, K., & K., S. M. (2023, May 12). Case Report of a Glioma Patient with Homozygous Missense Amino Acid Substitution in KDR Gene. Indian Journal of Medical and Paediatric Oncology, 44(03), 356–359. https://doi.org/10.1055/s-0043-1762919 In-Text Citation: (Uppaluri et al.,2023)
  • Thromboembolic events in advanced non-small cell lung cancer. Annals of Oncology (2019)30(suppl_2);ii38-1168.10.1093/annoc/mdz063
  • Rising thyroid cancer incidence in Kerala : Is it real or over diagnosis ? J Clin Oncol37(15_suppl):e17589. May 2019
  • The value of low, Lxed, singledose rasburicase in the prevention and treatment of tumor lysis syndrome. J Clin Oncol 37, 2019(suppl;e 18558)
  • The association of uterine motion with bladder volume during radiotherapy in gynaecological malignancies. Journal of Cancer Metastasis and Treatment.2016;2(4):139
  • Incidence of second primary malignant neoplasm in Malwa region of Central India - Journal of Cancer Research and Therapeutics,14(5),999.
  • Orbital metastasis as the presenting feature of carcinoma breast, Indian Journal of cancer education and research. 4.67-70.10.21088/ijcer.2321.9815.4216.5.
  • Permetrexed-Associated Hyperpigmented Skin Rash. American Journal of therapeutics. U.S. National Fibrary of Medicine;2020.
Conferences
  • Genitourinary Tumours Summit, Mumbai
  • ESMO ASIA CONGRESS, Singapore
  • IDCON Infectious Disease Update - Medicover Hospitals, Hyderabad
  • Indian Myeloma Congress, NIMS, Hyderabad
  • Annual year in review Breast Cancer, Mumbai
  • Annual Oncology Breast Cancer Conference, Thrissur
  • PRECEPTORSHIP COURSE by ESMO: Metastatic Bladder and kidney Cancer, Singapore
  • PRECEPTORSHIP COURSE by ESMO: Multidisciplinary management, standards of care, therapeutic targets and future perspectives in ProstateCancer, Singapore
  • Innovations in Oncology 5th Edition, Delhi
  • Association of Physicians of India - Kerala chapter
  • Indian Myeloma Congress, ACTREC, TMC, Mumbai
  • ISO-ISMPO, Cancers in the Indian subcontinent: How to manage better?,Indore
  • 3rd Annual Year end review Fung Cancer edition, Mumbai
  • HEMATOCON, National Conference, 2018, Kochi
  • Oncology 2018: International Conference on multidisciplinary management of common cancers
Dissertations
  • DM DISSERTATION: Distress among Cancer patients and factors associated with it: A prospective observational study
  • MD DISSERTATION: Treatment of carcinoma cervix with cobalt-60 high dose rate brachytherapy unit: A domestic study
24*7 Appointments
24*7 Appointments